Ascendiant Capital Starts Envoy Medical (COCH) at Buy

Ascendiant Capital analyst Edward Woo initiates coverage on Envoy Medical (NASDAQ: COCH) with a Buy rating and a price target of $8.50.

The analyst comments: "We are initiating coverage of Envoy Medical with a BUY rating and a 12-month price target of $8.50. Envoy Medical is a hearing health company focused on providing innovative medical technologies for hearing loss. The company’s medical devices are designed to bring both providers and patients hearing devices with improved technology, ease of use, access, usability, independence, and quality of life."

For an analyst ratings summary and ratings history on Envoy Medical click here. For more ratings news on Envoy Medical click here.

Shares of Envoy Medical closed at $2.29 yesterday.

You May Also Be Interested In

• Jefferies Starts Freenome Inc. (FRNM) at Buy
• Phillips 66, Marathon Merger Talks Collapsed - Semafor
• Intuitive Machines Inc. (LUNR) PT Lowered to $32 at Cantor Fitzgerald, Reaffirms Overweight Rating